Top

Published in:

Open Access 01-12-2021 | Parkinson's Disease | Original Communication

Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial

Authors: Nele Schmidt, Inken Tödt, Daniela Berg, Christian Schlenstedt, Ann-Kristin Folkerts, Anja Ophey, Karina Dimenshteyn, Saskia Elben, Lars Wojtecki, Inga Liepelt-Scarfone, Claudia Schulte, Patricia Sulzer, Carsten Eggers, Elke Kalbe, Karsten Witt

Published in: Journal of Neurology | Issue 12/2021

Abstract

Background

Meta-analyses indicate positive effects of cognitive training (CT) in patients with Parkinson’s disease (PD), however, most previous studies had small sample sizes and did not evaluate long-term follow-up. Therefore, a multicenter randomized controlled, single-blinded trial (Train-ParC study) was conducted to examine CT effects in PD patients with mild cognitive impairment (PD-MCI). Immediately after CT, an enhancement of executive functions was demonstrated. Here, we present the long-term results 6 and 12 months after CT.

Methods

At baseline, 64 PD-MCI patients were randomized to a multidomain CT group (n = 33) or to a low-intensity physical activity training control group (PT) (n = 31). Both interventions included 90 min training sessions twice a week for 6 weeks. 54 patients completed the 6 months (CT: n = 28, PT: n = 26) and 49 patients the 12 months follow-up assessment (CT: n = 25, PT: n = 24). Primary study outcomes were memory and executive functioning composite scores. Mixed repeated measures ANOVAs, post-hoc t tests and multiple regression analyses were conducted.

Results

We found a significant time x group interaction effect for the memory composite score (p = 0.006, η² = 0.214), but not for the executive composite score (p = 0.967, η² = 0.002). Post-hoc t tests revealed significant verbal and nonverbal memory improvements from pre-intervention to 6 months, but not to 12 months follow-up assessment in the CT group. No significant predictors were found for predicting memory improvement after CT.

Conclusions

This study provides Class 1 evidence that multidomain CT enhances memory functioning in PD-MCI after 6 months but not after 12 months, whereas executive functioning did not change in the long-term.

Clinical trial registration

German Clinical Trials Register (ID: DRKS00010186), 21.3.2016 (The study registration is outlined as retrospective due to an administrative delay. The first patient was enrolled three months after the registration process was started. A formal confirmation of this process from the German Clinical Trials Register can be obtained from the authors.)

Available only for authorised users

Monastero R, Cicero CE, Baschi R, Davì M, Luca A, Restivo V et al (2018) Mild cognitive impairment in Parkinson’s disease. The Parkinson’s disease cognitive study (PACOS). J Neurol 265:1050–1058. https://doi.org/10.1007/s00415-018-8800-4CrossRefPubMed

Wiesli D, Meyer A, Fuhr P, Gschwandtner U (2017) Influence of Mild cognitive impairment, depression, and anxiety on the quality of life of patients with Parkinson disease. Dement Geriatr Cogn Dis Extra 7:297–308. https://doi.org/10.1159/000478849CrossRefPubMedPubMedCentral

de Lau LML, Verbaan D, Marinus J, van Hilten JJ (2014) Survival in Parkinson’s disease. Relation with motor and non-motor features. Parkinsonism Relat Disord 20:613–616. https://doi.org/10.1016/j.parkreldis.2014.02.030CrossRefPubMed

Rolinski M, Fox C, Maidment I, McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson’s disease dementia and cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006504.pub2CrossRefPubMedPubMedCentral

McShane R, Westby MJ, Roberts E, Minakaran N, Schneider L, Farrimond LE et al (2019) Memantine for dementia. Cochrane Database Syst Rev 3:CD003154. https://doi.org/10.1002/14651858.CD003154.pub6CrossRefPubMed

Leung IHK, Walton CC, Hallock H, Lewis SJG, Valenzuela M, Lampit A (2015) Cognitive training in Parkinson disease. A systematic review and meta-analysis. Neurology 85:1843–1851. https://doi.org/10.1212/WNL.0000000000002145CrossRefPubMedPubMedCentral

Lawrence BJ, Gasson N, Bucks RS, Troeung L, Loftus AM (2017) Cognitive training and noninvasive brain stimulation for cognition in Parkinson’s disease: a meta-analysis. Neurorehabil Neural Repair 31:597–608. https://doi.org/10.1177/1545968317712468CrossRefPubMed

Pupíková M, Rektorová I (2020) Non-pharmacological management of cognitive impairment in Parkinson’s disease. J Neural Transm 127:799–820. https://doi.org/10.1007/s00702-019-02113-wCrossRefPubMed

Orgeta V, McDonald KR, Poliakoff E, Hindle JV, Clare L, Leroi I (2020) Cognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD011961.pub2CrossRefPubMedPubMedCentral

10.

Edwards JD, Hauser RA, O’Connor ML, Valdés EG, Zesiewicz TA, Uc EY (2013) Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology 81:1284–1290. https://doi.org/10.1212/WNL.0b013e3182a823baCrossRefPubMedPubMedCentral

11.

Fellman D, Salmi J, Ritakallio L, Ellfolk U, Rinne JO, Laine M (2020) Training working memory updating in Parkinson’s disease. A randomised controlled trial. Neuropsychol Rehabil 30:673–708. https://doi.org/10.1080/09602011.2018.1489860CrossRefPubMed

12.

Zimmermann R, Gschwandtner U, Benz N, Hatz F, Schindler C, Taub E et al (2014) Cognitive training in Parkinson disease. Cognition-specific vs nonspecific computer training. Neurology 82:1219–1226. https://doi.org/10.1212/WNL.0000000000000287CrossRefPubMed

13.

París AP, Saleta HG, de La Cruz Crespo Maraver M, Silvestre E, Freixa MG, Torrellas CP et al (2011) Blind randomized controlled study of the efficacy of cognitive training in Parkinson’s disease. Mov Disord 26:1251–1258. https://doi.org/10.1002/mds.23688CrossRefPubMed

14.

Ophey A, Rehberg S, Giehl K, Eggers C, Reker P, van Eimeren T et al (2021) Predicting working memory training responsiveness in Parkinson’s disease: both “System Hardware” and room for improvement are needed. Neurorehabil Neural Repair 35:117–130. https://doi.org/10.1177/1545968320981956CrossRefPubMed

15.

Kalbe E, Folkerts A-K, Ophey A, Eggers C, Elben S, Dimenshteyn K et al (2020) Enhancement of executive functions but not memory by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: a multicenter randomized controlled trial. Parkinson’s Disease 2020:1–15. https://doi.org/10.1155/2020/4068706CrossRef

16.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 55:181–184. https://doi.org/10.1136/jnnp.55.3.181CrossRef

17.

Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC et al (2012) Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines. Mov Disord 27:349–356. https://doi.org/10.1002/mds.24893CrossRefPubMedPubMedCentral

18.

Jessen F, Wolfsgruber S, Wiese B, Bickel H, Mösch E, Kaduszkiewicz H et al (2014) AD dementia risk in late MCI, in early MCI, and in subjective memory impairment. Alzheimer’s Dementia 10:76–83. https://doi.org/10.1016/j.jalz.2012.09.017CrossRefPubMed

19.

Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.xCrossRefPubMed

20.

Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707. https://doi.org/10.1002/mds.21507CrossRefPubMed

21.

Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA et al (2007) Diagnostic procedures for Parkinson’s disease dementia: recommendations from the movement disorder society task force. Mov Disord 22:2314–2324. https://doi.org/10.1002/mds.21844CrossRefPubMed

22.

Beck AT, Steer RA, Brown GK (1996) Manual for the Beck depression inventory-II. Psychological Corporation, San Antonio, TX, USA

23.

Baller G, Kalbe E, Kaesberg S, Kessler J (2009) Neurovitalis: ein neuropsychologisches Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit. ProLog, Cologne, Germany

24.

Baller G, Folkerts AK, Kessler J, Kalbe E (2021) NEUROvitalis Parkinson: ein wissenschaftlich fundiertes Gruppenprogramm zur Förderung der geistigen Leistungsfähigkeit bei Morbus Parkinson Patienten. ProLog, Cologne, Germany

25.

Niemann H, Sturm W, Thöne-Otto A, Willmes K (2008) CVLT. California Verbal Learning Test. Deutsche Adaptation. Pearson, Frankfurt am Main

26.

Strauss E, Sherman EMS, Spreen O (2006) Compendium of neuropsychological tests: administration, norms and commentary. Oxford University Press, New York, NY

27.

Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeits-Test: RWT. Hogrefe, Göttingen

28.

Schretlen DJ (2011) M-WCST, Modified Wisconsin Card Sorting Test. Psychological Assessment Resources, Lutz, FL

29.

Wilson BA, Emslie H, Evans JJ, Alderman N, Burgess PW (1991) Behavioural Assessment of the Dysexecutive Syndrome (BADS). Pearson, London

30.

Brickenkamp R, Schmidt-Atzert L, Liepmann D (2010) Test d2—Revision. Aufmerksamkeits- und Konzentrationstest. Hogrefe, Göttingen

31.

Wechsler D (1997) Wechsler adult intelligence scale—third edition (WAIS-III). Pearson, London

32.

Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O (1983) Benton judgement of line orientation. Psychological Assessment Resources, Lutz, FL

33.

Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G et al (1989) The consortium to establish a registry for Alzheimer’s disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 39:1159–1165. https://doi.org/10.1212/wnl.39.9.1159CrossRefPubMed

34.

Kalbe E, Reinhold N, Ender U, Kessler J (2010) ACL—Aphasie-Check-Liste. ProLog, Cologne

35.

Erzigkeit H, Lehfeld H (2010) Bayer ADL-Skala. Eine Skala zur Erfassung von Beeinträchtigungen der Alltagskompetenz bei älteren Patienten mit Einbußen der kognitiven Leistungsfähigkeit. Pearson, Frankfurt am Main

36.

Washburn RA, Smith KW, Jette AM, Janney CA (1993) The physical activity scale for the elderly (PASE): development and evaluation. J Clin Epidemiol 46:153–162. https://doi.org/10.1016/0895-4356(93)90053-4CrossRefPubMed

37.

Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N (1997) The Parkinson’s disease questionnaire (PDQ-39). Development and validation of a Parkinson’s disease summary index score. Age Ageing 26:353–357. https://doi.org/10.1093/ageing/26.5.353CrossRefPubMed

38.

Zimmermann P, Merser C, Poser U, Sedelmeier P (1991) Ein Fragebogen erlebter Defizite der Aufmerksamkeit (FEDA). University Institute of Psychology, Freiburg

39.

Fahn S, Elton RL, Members of the UPDRS development committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB et al (eds) Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information. Florham Park, NJ, pp 153–164

40.

Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165–170. https://doi.org/10.1016/s1353-8020(99)00062-0CrossRefPubMed

41.

Cohen J (1977) Statistical power analysis for the behavioral sciences. Academic Press, New York, NY

42.

Langbaum JBS, Rebok GW, Bandeen-Roche K, Carlson MC (2009) Predicting memory training response patterns: results from ACTIVE. J Gerontol B Psychol Sci Soc Sci 64:14–23. https://doi.org/10.1093/geronb/gbn026CrossRefPubMed

43.

Jean L, Simard M, Wiederkehr S, Bergeron M-E, Turgeon Y, Hudon C et al (2010) Efficacy of a cognitive training programme for mild cognitive impairment: results of a randomised controlled study. Neuropsychol Rehabil 20:377–405. https://doi.org/10.1080/09602010903343012CrossRefPubMed

44.

Whitlock LA, McLaughlin AC, Allaire JC (2012) Individual differences in response to cognitive training: using a multi-modal, attentionally demanding game-based intervention for older adults. Comput Hum Behav 28:1091–1096. https://doi.org/10.1016/j.chb.2012.01.012CrossRef

45.

Fairchild JK, Friedman L, Rosen AC, Yesavage JA (2013) Which older adults maintain benefit from cognitive training? Use of signal detection methods to identify long-term treatment gains. Int Psychogeriatr 25:607–616. https://doi.org/10.1017/S1041610212002049CrossRefPubMed

46.

Rebok GW, Langbaum JBS, Jones RN, Gross AL, Parisi JM, Spira AP et al (2013) Memory training in the ACTIVE study: how much is needed and who benefits? J Aging Health 25:21S-42S. https://doi.org/10.1177/0898264312461937CrossRefPubMed

47.

Rahe J, Becker J, Fink GR, Kessler J, Kukolja J, Rahn A et al (2015) Cognitive training with and without additional physical activity in healthy older adults: cognitive effects, neurobiological mechanisms, and prediction of training success. Front Aging Neurosci 7:187. https://doi.org/10.3389/fnagi.2015.00187CrossRefPubMedPubMedCentral

48.

Roheger M, Kalbe E, Corbett A, Brooker H, Ballard C (2020) Predictors of changes after reasoning training in healthy adults. Brain Behav 10:e01861. https://doi.org/10.1002/brb3.1861CrossRefPubMedPubMedCentral

49.

Roheger M, Meyer J, Kessler J, Kalbe E (2020) Predicting short- and long-term cognitive training success in healthy older adults: who benefits? Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 27:351–369. https://doi.org/10.1080/13825585.2019.1617396CrossRefPubMed

50.

Kalbe E, Rehberg SP, Heber I, Kronenbuerger M, Schulz JB, Storch A et al (2016) Subtypes of mild cognitive impairment in patients with Parkinson’s disease: evidence from the LANDSCAPE study. J Neurol Neurosurg Psychiatry 87:1099–1105. https://doi.org/10.1136/jnnp-2016-313838CrossRefPubMed

51.

Peña J, Ibarretxe-Bilbao N, García-Gorostiaga I, Gomez-Beldarrain MA, Díez-Cirarda M, Ojeda N (2014) Improving functional disability and cognition in Parkinson disease: randomized controlled trial. Neurology 83:2167–2174. https://doi.org/10.1212/WNL.0000000000001043CrossRefPubMedPubMedCentral

52.

Petrelli A, Kaesberg S, Barbe MT, Timmermann L, Fink GR, Kessler J et al (2014) Effects of cognitive training in Parkinson’s disease: a randomized controlled trial. Parkinsonism Relat Disord 20:1196–1202. https://doi.org/10.1016/j.parkreldis.2014.08.023CrossRefPubMed

53.

Alloni A, Quaglini S, Panzarasa S, Sinforiani E, Bernini S (2018) Evaluation of an ontology-based system for computerized cognitive rehabilitation. Int J Med Inform 115:64–72. https://doi.org/10.1016/j.ijmedinf.2018.04.005CrossRefPubMed

54.

Lawrence BJ, Gasson N, Johnson AR, Booth L, Loftus AM (2018) Cognitive training and transcranial direct current stimulation for mild cognitive impairment in Parkinson’s disease: a randomized controlled trial. Parkinson’s Disease 2018:4318475. https://doi.org/10.1155/2018/4318475CrossRefPubMedPubMedCentral

55.

Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA (2003) The relationship between executive function and verbal memory in Parkinson’s disease. Brain Cogn 52:343–352. https://doi.org/10.1016/S0278-2626(03)00180-5CrossRefPubMed

56.

O’Brien TJ, Wadley V, Nicholas AP, Stover NP, Watts R, Griffith HR (2009) The contribution of executive control on verbal-learning impairment in patients with Parkinson’s disease with dementia and Alzheimer’s disease. Arch Clin Neuropsychol 24:237–244. https://doi.org/10.1093/arclin/acp029CrossRefPubMedPubMedCentral

57.

Hill BD, Alosco M, Bauer L, Tremont G (2012) The relation of executive functioning to CVLT-II learning, memory, and process indexes. Appl Neuropsychol Adult 19:198–206. https://doi.org/10.1080/09084282.2011.643960CrossRefPubMed

58.

Brooks BL, Weaver LE, Scialfa CT (2006) Does impaired executive functioning differentially impact verbal memory measures in older adults with suspected dementia? Clin Neuropsychol 20:230–242. https://doi.org/10.1080/13854040590947461CrossRefPubMed

59.

Alexander MP, Stuss DT, Fansabedian N (2003) California Verbal Learning Test: performance by patients with focal frontal and non-frontal lesions. Brain 126:1493–1503. https://doi.org/10.1093/brain/awg128CrossRefPubMed

60.

Janowsky JS, Thomas-Thrapp LJ (1993) Complex figure recall in the elderly: a deficit in memory or constructional strategy? J Clin Exp Neuropsychol 15:159–169. https://doi.org/10.1080/01688639308402554CrossRefPubMed

61.

Westervelt H (2000) The impact of organizational strategy on recall of the Rey-Osterrieth complex figure. Arch Clin Neuropsychol 15:684. https://doi.org/10.1016/S0887-6177(00)80060-8CrossRef

62.

Moro V, Condoleo MT, Valbusa V, Broggio E, Moretto G, Gambina G (2015) Cognitive stimulation of executive functions in mild cognitive impairment: specific efficacy and impact in memory. Am J Alzheimers Dis Other Demen 30:153–164. https://doi.org/10.1177/1533317514539542CrossRefPubMed

63.

Yudkin PL, Stratton IM (1996) How to deal with regression to the mean in intervention studies. The Lancet 347:241–243. https://doi.org/10.1016/S0140-6736(96)90410-9CrossRef

Title: Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial
Authors: Nele Schmidt
Inken Tödt
Daniela Berg
Christian Schlenstedt
Ann-Kristin Folkerts
Anja Ophey
Karina Dimenshteyn
Saskia Elben
Lars Wojtecki
Inga Liepelt-Scarfone
Claudia Schulte
Patricia Sulzer
Carsten Eggers
Elke Kalbe
Karsten Witt
Publication date: 01-12-2021
Publisher: Springer Berlin Heidelberg
Keywords: Parkinson's Disease
Mild Neurocognitive Disorder
Published in: Journal of Neurology / Issue 12/2021
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-021-10568-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Memory enhancement by multidomain group cognitive training in patients with Parkinson’s disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial

Abstract

Background

Methods

Results

Conclusions

Clinical trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Clinical trial registration

Please log in to get access to this content

Other articles of this Issue 12/2021

A matter of atrophy: differential impact of brain and spine damage on disability worsening in multiple sclerosis

Spinocerebellar ataxia type 23 (SCA23): a review

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder

Cognitive evaluation in cerebral small vessel disease: towards an evidence-based identification of the reference standards. Part 1. A systematic review and qualitative data synthesis

Iron-sensitive magnetic resonance imaging in Parkinson’s disease: a systematic review and meta-analysis

Mutations in MT-ATP6 are a frequent cause of adult-onset spinocerebellar ataxia